Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,416.80
(
0.44%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
107.24
(
2.71%
)
Bitcoin
77,594.00
(
1.64%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122898
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: gofishmarko post# 1068

Friday, 05/18/2007 6:18:53 PM

Friday, May 18, 2007 6:18:53 PM

Post# of 3757
>I maintain that the victor [for second-line treatment] is currently Hepsera based on scientific principles, until IDIX presents data to the contrary.<

No argument there, but NVS/IDIX are running the second-line trial I cited for exactly this reason.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote